Data Sharing Works

Seven years ago, NIH, FDA, researchers from industry, academia, and some nonprofit groups got together to find biomarkers for Alzheimer's disease. Now, the New York Times' Gina Kolata says the collaboration has resulted in several papers on early diagnosis of Alzheimer's using PET scans and spinal fluid tests, and more than 100 drug studies in progress. The key to the project, Kolata says, is the data sharing aspect.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.